Company intelligence / Profile preview

Rinovum Women's Health

Pittsburgh / Monroeville, Pennsylvania, United Statesinnovationworks.org ↗

Ownership: Private
Employees: ~13
Development stage: Other

Overview

Revive™, an FDA-cleared reusable urethral support device for stress urinary incontinence, demonstrated a clinically significant reduction in symptoms for 71% of women in a single-arm clinical trial. The Stork® OTC conception aid was the first over-the-counter product of its kind to assist with at-home fertility.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Rinovum Women's Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rinovum Women's Health.

Explore the full profile